These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17765414)

  • 1. Spherical crystallization of benzoic acid.
    Katta J; Rasmuson AC
    Int J Pharm; 2008 Feb; 348(1-2):61-9. PubMed ID: 17765414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanisms of formation of spherical agglomerates.
    Thati J; Rasmuson AC
    Eur J Pharm Sci; 2011 Mar; 42(4):365-79. PubMed ID: 21216285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particle engineering of benzoic acid by spherical agglomeration.
    Thati J; Rasmuson ÅC
    Eur J Pharm Sci; 2012 Apr; 45(5):657-67. PubMed ID: 22266212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spherical crystallization of drugs.
    Kovačič B; Vrečer F; Planinšek O
    Acta Pharm; 2012 Mar; 62(1):1-14. PubMed ID: 22472445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
    Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
    Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of preparation method on compactability of paracetamol granules and agglomerates.
    Fichtner F; Rasmuson AC; Alander EM; Alderborn G
    Int J Pharm; 2007 May; 336(1):148-58. PubMed ID: 17196775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of binder liquid type on spherical crystallization.
    Maghsoodi M; Hajipour A
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1468-75. PubMed ID: 23937581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique.
    Maghsoodi M
    Pharm Dev Technol; 2011 Oct; 16(5):474-82. PubMed ID: 20557281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):72-82. PubMed ID: 18082385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental study of the GAS process for producing microparticles of beclomethasone-17,21-dipropionate suitable for pulmonary delivery.
    Bakhbakhi Y; Charpentier PA; Rohani S
    Int J Pharm; 2006 Feb; 309(1-2):71-80. PubMed ID: 16412594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of crystallization processes in case of glycine crystallization].
    Aigner Z; Szegedi A; Szabadi V; Ambrus R; Sovány T; Szabóné Révész P
    Acta Pharm Hung; 2012; 82(2):61-8. PubMed ID: 22870778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
    Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
    Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface treatment: a potential approach for enhancement of solid-state photostability.
    Ramadan A; El-Massik M; El-Khordagui L; Daabis N; Hammouda Y
    Int J Pharm; 2006 Jan; 307(2):141-9. PubMed ID: 16289573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):94-105. PubMed ID: 17981448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of deformable talc agglomerates prepared by crystallo-co-agglomeration technique for generating heterogeneous matrix.
    Jadhav N; Pawar A; Paradkar A
    AAPS PharmSciTech; 2007 Jul; 8(3):E59. PubMed ID: 17915809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Milling of agglomerates in an impact mill.
    Verheezen JJ; van der Voort Maarschalk K; Faassen F; Vromans H
    Int J Pharm; 2004 Jun; 278(1):165-72. PubMed ID: 15158958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, evaluation and need of spherical crystallization in case of high speed direct tabletting.
    Pandey S; Patil AT
    Curr Drug Deliv; 2014; 11(2):179-90. PubMed ID: 23848355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of beta-haematin formation from suspensions of haematin in aqueous benzoic acid.
    Egan TJ; Tshivhase MG
    Dalton Trans; 2006 Nov; (42):5024-32. PubMed ID: 17060988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Process parameters and morphology in puerarin, phospholipids and their complex microparticles generation by supercritical antisolvent precipitation.
    Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
    Int J Pharm; 2008 Jul; 359(1-2):35-45. PubMed ID: 18440736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of micromeritic properties of an active pharmaceutical ingredient on its compaction behavior.
    Bindra DS; Desikan S
    Pharm Dev Technol; 2015 Mar; 20(2):129-38. PubMed ID: 24219704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.